<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37892676</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>20</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Evolution of Cardiovascular Risk Factors in Post-COVID Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6538</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12206538</ELocationID><Abstract><AbstractText>(1) Background: SARS-CoV-2 infection has been a subject of extensive discussion in the medical field, particularly in relation to the risk factors and effective treatment strategies for reducing the negative health outcomes associated with the virus. However, researchers indicate that individuals in the recovery phase after COVID-19 experience a range of symptoms that significantly impact their overall well-being and quality of life. At present, there is insufficient evidence to substantiate the claim that patients in the post-acute phase of COVID-19 are at an elevated risk of developing new-onset hypertension or even metabolic syndrome. The current study aimed to assess the risk of cardiovascular diseases after COVID-19 and the optimal treatment of these conditions. (2) Methods: This research was conducted at the Cardiovascular Rehabilitation Clinic of the Iasi Clinical Rehabilitation Hospital (Romania) between the 1st of September and 31st of December 2022. From a total of 551 patients hospitalized in that period, 70 patients with multiple comorbidities were selected. This study included patients over 18 years old who were diagnosed with COVID-19 within the past 30 days. (3) Results: The included patients were mostly women (62.9%) from the urban area (61.4%). Comparing the post-COVID-19 period to the pre-COVID-19 one, it was observed that the risk of hypertension increased from 69.57% to 90% among the subjects (<i>p</i> = 0.005). Risk factors for the new onset of hypertension were identified as age, female gender, and an elevated body mass index. Moreover, the number of patients with dyslipidemia doubled, and a higher body mass index was noted. (4) Conclusions: Our findings suggest that patients affected by COVID-19 are at an increased risk of developing hypertension and related disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdulan</LastName><ForeName>Irina Mihaela</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Department of Medical Specialties I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Rehabilitation Hospital, 700661 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feller</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Clinical Rehabilitation Hospital, 700661 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oancea</LastName><ForeName>Andra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1356-9581</Identifier><AffiliationInfo><Affiliation>Department of Medical Specialties I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Rehabilitation Hospital, 700661 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma&#x219;taleru</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0008-9696</Identifier><AffiliationInfo><Affiliation>Department of Medical Specialties I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Rehabilitation Hospital, 700661 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexa</LastName><ForeName>Anisia Iuliana</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Surgery II, Discipline of Ophthalmology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negru</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Specialties I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cump&#x103;t</LastName><ForeName>Carmen Marinela</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-2564-537X</Identifier><AffiliationInfo><Affiliation>Department of Medical Specialties I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Rehabilitation Hospital, 700661 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leon</LastName><ForeName>Maria Magdalena</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Medical Specialties I, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Rehabilitation Hospital, 700661 Iasi, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">dyslipidemia</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">obesity</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37892676</ArticleId><ArticleId IdType="pmc">PMC10607829</ArticleId><ArticleId IdType="doi">10.3390/jcm12206538</ArticleId><ArticleId IdType="pii">jcm12206538</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  Coronavirus Disease (COVID-19)  [(accessed on 11 July 2023)].  Available online:  https://www.who.int/health-topics/coronavirus#tab=tab_1.</Citation></Reference><Reference><Citation>Nishiga M., Wang D.W., Han Y., Lewis D.B., Wu J.C. COVID-19 and cardiovascular disease: From basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 2020;17:543&#x2013;558. doi: 10.1038/s41569-020-0413-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L., Fu M., Li Y., Hu S., Luo J., Chen Z., Yu J., Li W., Dong R., Yang Y., et al. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis. Clin. Cardiol. 2020;43:1478&#x2013;1493. doi: 10.1002/clc.23465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23465</ArticleId><ArticleId IdType="pmc">PMC7675427</ArticleId><ArticleId IdType="pubmed">33026120</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D., Ng R., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata S., Kobayashi K., Tanaka M., Asayama K., Yamamoto E., Nakagami H., Hoshide S., Kishi T., Matsumoto C., Mogi M., et al. COVID-19 pandemic and hypertension: An updated report from the Japanese Society of Hypertension project team on COVID-19. Hypertens. Res. 2023;46:589&#x2013;600. doi: 10.1038/s41440-022-01134-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-01134-5</ArticleId><ArticleId IdType="pmc">PMC9780104</ArticleId><ArticleId IdType="pubmed">36550205</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K., Ren S., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Guo Y., Lipsitch M., Daugherty S.E. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2022;376:e068414. doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto C., Shibata S., Kishi T., Morimoto S., Mogi M., Yamamoto K., Kobayashi K., Tanaka M., Asayama K., Yamamoto E., et al. Long COVID and hypertension-related disorders: A report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens. Res. 2023;46:601&#x2013;619. doi: 10.1038/s41440-022-01145-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-01145-2</ArticleId><ArticleId IdType="pmc">PMC9793823</ArticleId><ArticleId IdType="pubmed">36575228</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed S., Tadic M., Larsen T.H., Grassi G., Mancia G. Coronavirus disease 2019 and cardiovascular complications: Focused clinical review. J. Hypertens. 2021;39:1282&#x2013;1292. doi: 10.1097/HJH.0000000000002819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002819</ArticleId><ArticleId IdType="pmc">PMC9904438</ArticleId><ArticleId IdType="pubmed">33687179</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373:n1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Medetalibeyoglu A., Emet S., Kose M., Akpinar T.S., Senkal N., Catma Y., Kaytaz A.M., Genc S., Omer B., Tukek T. Serum Endocan Levels on Admission Are Associated With Worse Clinical Outcomes in COVID-19 Patients: A Pilot Study. Angiology. 2021;72:187&#x2013;193. doi: 10.1177/0003319720961267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003319720961267</ArticleId><ArticleId IdType="pubmed">32969233</ArticleId></ArticleIdList></Reference><Reference><Citation>Akpek M. Does COVID-19 Cause Hypertension? Angiology. 2022;73:682&#x2013;687. doi: 10.1177/00033197211053903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197211053903</ArticleId><ArticleId IdType="pmc">PMC9260192</ArticleId><ArticleId IdType="pubmed">34889662</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata S., Arima H., Asayama K., Hoshide S., Ichihara A., Ishimitsu T., Kario K., Kishi T., Mogi M., Nishiyama A., et al. Hypertension and related diseases in the era of COVID-19: A report from the Japanese Society of Hypertension Task Force on COVID-19. Hypertens. Res. 2020;43:1028&#x2013;1046. doi: 10.1038/s41440-020-0515-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-020-0515-0</ArticleId><ArticleId IdType="pmc">PMC7393334</ArticleId><ArticleId IdType="pubmed">32737423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M., Rigatelli G., Bilato C., Pasquetto G., Mazza A. Risk of Incident New-Onset Arterial Hypertension After COVID-19 Recovery: A Systematic Review and Meta-analysis. High Blood Press. Cardiovasc. Prev. 2023;30:227&#x2013;233. doi: 10.1007/s40292-023-00574-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-023-00574-5</ArticleId><ArticleId IdType="pmc">PMC10105348</ArticleId><ArticleId IdType="pubmed">37060396</ArticleId></ArticleIdList></Reference><Reference><Citation>Colangelo L.A., Yano Y., Jacobs D.R., Jr., Lloyd-Jones D.M. Association of Resting Heart Rate With Blood Pressure and Incident Hypertension over 30 Years in Black and White Adults: The CARDIA Study. Hypertension. 2020;76:692&#x2013;698. doi: 10.1161/HYPERTENSIONAHA.120.15233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15233</ArticleId><ArticleId IdType="pmc">PMC7430042</ArticleId><ArticleId IdType="pubmed">32783760</ArticleId></ArticleIdList></Reference><Reference><Citation>Aladin A.I., Al Rifai M., Rasool S.H., Keteyian S.J., Brawner C.A., Michos E.D., Blaha M.J., Al-Mallah M.H., McEvoy J.W. The Association of Resting Heart Rate and Incident Hypertension: The Henry Ford Hospital Exercise Testing (FIT) Project. Am. J. Hypertens. 2016;29:251&#x2013;257. doi: 10.1093/ajh/hpv095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpv095</ArticleId><ArticleId IdType="pubmed">26112864</ArticleId></ArticleIdList></Reference><Reference><Citation>Delali&#x107; &#x110;., Jug J., Prka&#x10d;in I. Arterial hypertension following COVID-19: A retrospective study of patients in a central european tertiary care center. Acta Clin. Croat. 2022;61:23&#x2013;27. doi: 10.20471/acc.2022.61.s1.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.20471/acc.2022.61.s1.03</ArticleId><ArticleId IdType="pmc">PMC9536154</ArticleId><ArticleId IdType="pubmed">36304797</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy H.M., Al-Gareeb A.I., Mostafa-Hedeab G., Kasozi K.I., Zirintunda G., Aslam A., Allahyani M., Welburn S.C., Batiha G.E. Effects of &#x3b2;-Blockers on the Sympathetic and Cytokines Storms in COVID-19. Front. Immunol. 2021;12:749291. doi: 10.3389/fimmu.2021.749291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.749291</ArticleId><ArticleId IdType="pmc">PMC8637815</ArticleId><ArticleId IdType="pubmed">34867978</ArticleId></ArticleIdList></Reference><Reference><Citation>Heriansyah T., Nur Chomsy I., Febrianda L., Farahiya Hadi T., Andri Wihastuti T. The Potential Benefit of Beta-Blockers for the Management of COVID-19 Protocol Therapy-Induced QT Prolongation: A Literature Review. Sci. Pharm. 2020;88:55. doi: 10.3390/scipharm88040055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/scipharm88040055</ArticleId></ArticleIdList></Reference><Reference><Citation>Solaimanzadeh I. Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19. Cureus. 2020;12:e8069. doi: 10.7759/cureus.8069.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.8069</ArticleId><ArticleId IdType="pmc">PMC7219014</ArticleId><ArticleId IdType="pubmed">32411566</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsagaff M.Y., Mulia E.P.B., Maghfirah I., Luke K., Nugraha D., Rachmi D.A., Septianda I., A&#x2019;yun M.Q. Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis. Diabetes Metab. Syndr. 2021;15:102210. doi: 10.1016/j.dsx.2021.102210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102210</ArticleId><ArticleId IdType="pmc">PMC8282943</ArticleId><ArticleId IdType="pubmed">34298269</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020;8:e21. doi: 10.1016/S2213-2600(20)30116-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30116-8</ArticleId><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Nikravesh M., Chukwuemeka U., Randazzo M., Flores P., Choday P., Raja A., Aseri M., Shivang S., Chaudhuri S., et al. Safety of ACEi and ARB in COVID-19 management: A retrospective analysis. Clin. Cardiol. 2022;45:759&#x2013;766. doi: 10.1002/clc.23836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23836</ArticleId><ArticleId IdType="pmc">PMC9110920</ArticleId><ArticleId IdType="pubmed">35481554</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnanenthiran S.R., Borghi C., Burger D., Caramelli B., Charchar F., Chirinos J.A., Cohen J.B., Cremer A., Di Tanna G.L., Duvignaud A., et al. Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension. J. Am. Heart Assoc. 2022;11:e026143. doi: 10.1161/JAHA.122.026143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.026143</ArticleId><ArticleId IdType="pmc">PMC9496439</ArticleId><ArticleId IdType="pubmed">36000426</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Fu W., Zhu C.J., Ding Z.H., Dong B.B., Sun B.Q., Chen R.C. Effect of continuing the use of renin&#x2013;angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: A systematic review, meta-analysis, and meta-regression analysis. BMC Infect Dis. 2023;23:53. doi: 10.1186/s12879-023-07994-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-07994-7</ArticleId><ArticleId IdType="pmc">PMC9872739</ArticleId><ArticleId IdType="pubmed">36694122</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  Obesity and Overweight. 2017.  [(accessed on 10 August 2023)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.</Citation></Reference><Reference><Citation>Steenblock C., Hassanein M., Khan E.G., Yaman M., Kamel M., Barbir M., Lorke D.E., Everett D., Bejtullah S., Lohmann T., et al. Obesity and COVID-19: What are the Consequences? Horm. Metab. Res. 2022;54:496&#x2013;502. doi: 10.1055/a-1878-9757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1878-9757</ArticleId><ArticleId IdType="pmc">PMC9427204</ArticleId><ArticleId IdType="pubmed">35724688</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hearn M., Liu J., Cudhea F., Micha R., Mozaffarian D. Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis. J. Am. Heart Assoc. 2021;10:e019259. doi: 10.1161/JAHA.120.019259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.019259</ArticleId><ArticleId IdType="pmc">PMC8174244</ArticleId><ArticleId IdType="pubmed">33629868</ArticleId></ArticleIdList></Reference><Reference><Citation>Nour T.Y., Altinta&#x15f; K.H. Effect of the COVID-19 pandemic on obesity and its risk factors: A systematic review. BMC Public Health. 2023;23:1018. doi: 10.1186/s12889-023-15833-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15833-2</ArticleId><ArticleId IdType="pmc">PMC10227822</ArticleId><ArticleId IdType="pubmed">37254139</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Risks and burdens of incident dyslipidaemia in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2023;11:120&#x2013;128. doi: 10.1016/S2213-8587(22)00355-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00355-2</ArticleId><ArticleId IdType="pmc">PMC9873268</ArticleId><ArticleId IdType="pubmed">36623520</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Luo P., Xu J., Yang L., Ma P., Tan X., Chen Q., Zhou M., Song S., Xia H., et al. Plasma Metabolomic Profiles in Recovered COVID-19 Patients without Previous Underlying Diseases 3 Months after Discharge. J. Inflamm. Res. 2021;14:4485&#x2013;4501. doi: 10.2147/JIR.S325853.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S325853</ArticleId><ArticleId IdType="pmc">PMC8434912</ArticleId><ArticleId IdType="pubmed">34522117</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorokin A.V., Karathanasis S.K., Yang Z.H., Freeman L., Kotani K., Remaley A.T. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. 2020;34:9843&#x2013;9853. doi: 10.1096/fj.202001451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001451</ArticleId><ArticleId IdType="pmc">PMC7361619</ArticleId><ArticleId IdType="pubmed">32588493</ArticleId></ArticleIdList></Reference><Reference><Citation>Roccaforte V., Daves M., Lippi G., Spreafico M., Bonato C. Altered lipid profile in patients with COVID-19 infection. J. Lab. Precis. Med. 2020;6:2. doi: 10.21037/jlpm-20-98.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jlpm-20-98</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Wang H., Cui G., Lu H., Wang L., Luo H., Chen X., Ren H., Sun R., Liu W., et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70:1253&#x2013;1265. doi: 10.1136/gutjnl-2020-323826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yao H., Zhang N., Wu J., Gao S., Guo J., Lu X., Cheng L., Luo R., Liang X., et al. Proteomic Analysis Identifies Prolonged Disturbances in Pathways Related to Cholesterol Metabolism and Myocardium Function in the COVID-19 Recovery Stage. J. Proteome Res. 2021;20:3463&#x2013;3474. doi: 10.1021/acs.jproteome.1c00054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00054</ArticleId><ArticleId IdType="pubmed">34080435</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffl H., Lang S.M. Long-term interplay between COVID-19 and chronic kidney disease. Int. Urol. Nephrol. 2023;55:1977&#x2013;1984. doi: 10.1007/s11255-023-03528-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-023-03528-x</ArticleId><ArticleId IdType="pmc">PMC9955527</ArticleId><ArticleId IdType="pubmed">36828919</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K., Wang Z., Qin M., Gao Y., Luo N., Xie W., Zou Y., Wang J., Ma X. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults. Front. Immunol. 2023;14:1113156. doi: 10.3389/fimmu.2023.1113156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1113156</ArticleId><ArticleId IdType="pmc">PMC10020204</ArticleId><ArticleId IdType="pubmed">36936964</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 29 September 2023)].  Available online:  https://covid19.who.int/table.</Citation></Reference><Reference><Citation>Buso G., Agabiti-Rosei C., Muiesan M.L. The relationship between COVID-19 vaccines and increased blood pressure: A word of caution. Eur. J. Intern. Med. 2023;111:27&#x2013;29. doi: 10.1016/j.ejim.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC9986138</ArticleId><ArticleId IdType="pubmed">36914539</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli F., Reboldi G., Trapasso M., Santilli G., Zappa M., Verdecchia P. Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis. J. Cardiovasc. Dev. Dis. 2022;9:150. doi: 10.3390/jcdd9050150.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd9050150</ArticleId><ArticleId IdType="pmc">PMC9147472</ArticleId><ArticleId IdType="pubmed">35621861</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeli F., Zappa M., Reboldi G., Gentile G., Trapasso M., Spanevello A., Verdecchia P. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure. Eur. J. Intern. Med. 2023;109:12&#x2013;21. doi: 10.1016/j.ejim.2022.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2022.12.004</ArticleId><ArticleId IdType="pmc">PMC9744686</ArticleId><ArticleId IdType="pubmed">36528504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappa M., Verdecchia P., Spanevello A., Visca D., Angeli F. Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine. Eur. J. Intern. Med. 2021;90:111&#x2013;113. doi: 10.1016/j.ejim.2021.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.013</ArticleId><ArticleId IdType="pmc">PMC8206586</ArticleId><ArticleId IdType="pubmed">34158234</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.N., Nguyen H.A., Le T.T.A., Truong T.T., Nguyen P.T., Nguyen T.T.H. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021. Vaccine. 2021;39:6485&#x2013;6491. doi: 10.1016/j.vaccine.2021.09.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.09.060</ArticleId><ArticleId IdType="pmc">PMC8485226</ArticleId><ArticleId IdType="pubmed">34607748</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeet Kaur R., Dutta S., Charan J., Bhardwaj P., Tandon A., Yadav D., Islam S., Haque M. Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database. Int. J. Gen. Med. 2021;14:3909&#x2013;3927. doi: 10.2147/IJGM.S324349.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S324349</ArticleId><ArticleId IdType="pmc">PMC8326931</ArticleId><ArticleId IdType="pubmed">34349544</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhanick B., Montastruc F., Tessier S., Brusq C., Bongard V., Senard J.M., Montastruc J.L., Herin F. Hypertension and COVID-19 vaccines: Are there any differences between the different vaccines? A safety signal. Eur. J. Clin. Pharmacol. 2021;77:1937&#x2013;1938. doi: 10.1007/s00228-021-03197-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-021-03197-8</ArticleId><ArticleId IdType="pmc">PMC8346776</ArticleId><ArticleId IdType="pubmed">34363519</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>